GlobeNewswire by notified

PCI Biotech to present at the 9th International mRNA Health Conference

Share

Oslo (Norway), 9 November 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced that it will present a poster at the 9th International mRNA Health Conference, a combined on-site and virtual event taking place November 9-10, 2021 in Berlin, Germany.

Today at 16:45 – 18:30 (CET), Dr. Anders Høgset, CSO, will on-site present a poster named ‘Photochemical internalisation (PCI) - enhanced and site-directed mRNA delivery by light-induced endosomal release’ giving an overview of PCI Biotech’s proprietary platform technology for use in the exciting field of mRNA-based therapies. Please find the poster enclosed.

Contact information:        
Per Walday, CEO        
pw@pcibiotech.no
Mobile: +47 917 93 429

About The International mRNA Health Conference
The International mRNA Health Conference is the premier meeting destination for industry and academic professionals to explore the rapidly advancing science and business of mRNA medicines. The conference provides participants with a platform for networking with experts, giving them an opportunity to learn more about developments in mRNA technology and to see scientific presentations by some of the most esteemed experts in the field. The event brings together over 650 attendees from leading pharma and biotech companies as well as academic institutions.

About PCI Biotech
PCI Biotech is a biopharmaceutical late-stage clinical development company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform. PCI is applied to three distinct anticancer paradigms: fimaChem (enhancement of chemotherapeutics for localised treatment of cancer), fimaVacc (T-cell induction technology for therapeutic vaccination), and fimaNAc (nucleic acid therapeutics delivery).

Photochemical internalisation induces triggered endosomal release that is used to unlock the true potential of a wide array of therapeutic modalities. The company’s lead programme fimaChem consists of a pivotal study in bile duct cancer, an orphan indication with a high unmet need and without approved products. fimaVacc applies a unique mode of action to enhance the essential cytotoxic effect of therapeutic cancer vaccines, which works in synergy with several other state-of-the-art vaccination technologies. fimaNAc utilises the endosomal release to provide intracellular delivery of nucleic acids, such as mRNA and RNAi therapeutics, thereby addressing one of the major bottlenecks facing this emerging and promising field.

For further information, please visit: www.pcibiotech.com

Forward-looking statements        
This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements. PCI Biotech disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

AMG Advanced Metallurgical Group N.V. Completes Issuance of $550 Million of Credit Facilities30.11.2021 22:00:00 CET | Press release

Amsterdam, 30November 2021--- AMG Advanced Metallurgical Group N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") is pleased to announce that it has entered into a new $350 million 7-year senior secured term loan B facility ("term loan") and a $200 million 5-year senior secured revolving credit facility ("revolver"). The total facility amount of $550 million replaces AMG’s existing credit facility and extends our term loan maturity from 2025 to 2028 and revolver maturity from 2023 to 2025. AMG will use the proceeds of the new term loan to refinance its existing credit facility. Further strengthening AMG’s commitment to Environmental, Social and Governance ("ESG"), we have embedded annual CO2 intensity reduction targets into the Revolving Credit Facility, making it a Sustainability Linked Loan. Moody's Investors Service ("Moody's") assigned a Ba3 rating to the new senior secured credit facility, affirmed our B2 corporate family rating and changed their outlook to positive from stable. S&P Global R

EPH European Property Holdings Limited (EPH) announces Third Quarter 2021 Financial Update30.11.2021 19:00:00 CET | Press release

30November 2021, Road Town, Tortola, BVI I Ad hoc announcement pursuant to Art. 53 LR In Q3 2021, there were no significant changes in the Company’s financial position and/or structure of its balance sheet in comparison to the published semi-annual report, given that fair value of investment properties was not revaluated as of 30 September 2021. In Q3 2021, the Company demonstrated stable performance compared to the last year. The rental properties continued generating sufficient cash to cover the Company’s operating expenses, service the debt and partially finance its investment program. The net rental income (NRI) increased from US$45.33 mln in the first 9 months of 2020 to US$ 49.38 mln for 9 months of 2021. Thereof, European properties acquired during 2020 generated a total NRI of US$ 7.48 mln (9 months of 2020: US$ 2.67 mln). The performance of the other European properties, as well as Russian properties remained almost unchanged as compared to the same period of 2020.During Q3 20

NEXTENSA NV/SA: SHARES – VOTING RIGHTS AND DENOMINATOR PUBLICATION IN COMPLIANCE WITH ART. 15 OF THE LAW OF 2 MAY 2007 (THE TRANSPARENCY ACT)30.11.2021 17:40:00 CET | Press release

NEXTENSA NV/SA: SHARES – VOTING RIGHTS AND DENOMINATOR PUBLICATION IN COMPLIANCE WITH ART. 15 OF THE LAW OF 2 MAY 2007 (THE TRANSPARENCY ACT) As previously announced1, the EGM of 19 July 2021 introduced the double voting right (loyalty voting right), in accordance with article 7:53 of the Code of Companies and Associations. This means, in accordance with article 28 of the articles of association, that double voting rights are granted to each fully paid-up share that has been continuously registered in the share register in the name of the same shareholder for at least two years. The other shares give right to one vote. The two-year period starts from the date of registration of the nominative shares in the share register. In compliance with article 15 of the aforementioned Transparency Act, every month the Company must publish, on its website and by means of a press release, the total capital, the changes to the total number of voting securities and the total number of voting rights, i

Change in the number of shares and votes in Sinch AB (publ)30.11.2021 17:35:00 CET | Press release

Stockholm, Sweden – November 30, 2021 – Sinch AB (publ), a global leader in cloud communications for mobile customer engagement, today announced that the number of shares and votes in Sinch AB (publ), registration number 556882-8908 (“Sinch”), amounts to 747,480,901 on November 30, 2021. The change in the number of shares and votes in November is a result of the issue of totally 1,317,537 new shares in connection with the closing of the acquisitions of MessageMedia and MessengerPeople, as previously communicated. For further information, please contact Ola Elmeland Investor Relations Director Mobile: +46 721 43 34 59 E-mail: investors@sinch.com Thomas Heath Chief Strategy Officer & Head of Investor Relations Mobile: +46 722 45 50 55 E-mail: investors@sinch.com About Sinch Sinch brings businesses and people closer with tools enabling personal engagement. Its leading cloud communications platform lets businesses reach every mobile phone on the planet, in seconds or less, through mobile m

Ändring av antalet aktier och röster i Sinch AB (publ)30.11.2021 17:35:00 CET | Pressemelding

Stockholm, Sverige – 30 november 2021 – Sinch AB (publ), en ledande global leverantör av molntjänster för kundinteraktion via mobilen, meddelade idag att antalet aktier och röster i Sinch AB (publ), org.nr 556882–8908 (”Sinch”), uppgår till 747 480 901 den 30 november 2021. Förändringen av antal aktier och röster under november har föranletts av att totalt 1 317 537 nya aktier har emitterats i samband med slutförandet av förvärven av MessageMedia och MessengerPeople, som tidigare har kommunicerats. För mer information, vänligen kontakta Ola Elmeland Investor Relations Director Mobile: +46 721 43 34 59 E-mail: investors@sinch.com Thomas Heath Chief Strategy Officer & Head of Investor Relations Mobile: +46 722 45 50 55 E-mail: investors@sinch.com Om Sinch Sinch utvecklar digitala verktyg som möjliggör en personlig interaktion mellan företag och individer. Med Sinch molnbaserade kommunikationsplattform kan företag nå världens alla mobiltelefoner – inom en eller ett par sekunder – via medd

GivingTuesday: NOVA Chemicals Expands Total COVID-19 Relief to US$1.25M with Additional Gifts30.11.2021 16:40:00 CET | Press release

Programs supporting mental health, food security, and overall community resiliency receive funding through corporate giving campaign Calgary, Alberta, Canada , Nov. 30, 2021 (GLOBE NEWSWIRE) -- NOVA Chemicals Corporation, 1000 Seventh Avenue S.W., Calgary, Alberta, Canada T2P 5L5 www.novachemicals.com | 403.750.3600 tel | 403.269.7410 fax NOVA Chemicals Corporation (“NOVA Chemicals”) today announced an additional US$600,000 commitment in COVID-19-related supports across our operational regions, bringing the total amount given for pandemic relief to US$1.25M, as part of efforts to meaningfully give back to our neighbors and their communities. “While we continue to see positive momentum toward a world with higher vaccination rates and fewer restrictions, the impacts felt by the pandemic will unfortunately have lasting effects,” said Mona Jasinski, SVP HR and Communications, NOVA Chemicals. “I am proud of NOVA’s commitment to ensuring there is food on the table for tens of thousands of pe

KICKS CHOSES WESTPAY AS PROVIDER OF PAYMENT SOLUTIONS30.11.2021 16:40:00 CET | Press release

Westpay has today signed an agreement with Kicks regarding payment solutions in Sweden, Norway, and Finland. The solution enables card payments as well as Swish, Vipps, Mobile Pay, and other alternative payment methods. The value of the initial order amounts close to SEK 4 million during the coming three years. - Kicks is a solid and well-known brand in the Nordics. The customer experience is a key element in their success. Westpay and our solutions enable all the features and solutions they need to level up their overall offering. They made an accurate and relevant assessment and knew that their payment solution was required to support them in their ongoing business today as well as tomorrow. Now, they have a future-proof solution that they can rely on in their future journey, says Hans Edin, CCO at Westpay. KICKS is the Nordic region's leading beauty chain and offers a holistic concept in makeup, fragrance, skin care and hair care. With experts in 250 stores in Sweden, Norway and Fin